DrugPatentWatch Database Preview
Patent: 9,662,450
» See Plans and Pricing
Summary for Patent: 9,662,450
| Title: | Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus |
| Abstract: | An article is described including an article surface, a primer coating or layer of SiOx, SiO.sub.xC.sub.y or SiN.sub.xC.sub.y applied to the article surface, and a deposit of lubricant applied to the primer coating or layer. The primer coating or layer of SiO.sub.x, SiO.sub.xC.sub.y or SiN.sub.xC.sub.y is applied by chemical vapor deposition of a polysiloxane or polysilazane precursor in the presence of oxygen. A first deposit of lubricant is applied to the primer coating or layer. The primer coating or layer improves the adhesion or wetting of the lubricant on the surface to be lubricated. Examples of such an article are a prefilled syringe having a barrel with a lubricated interior portion and a plunger tip that slides along it. Another example of such an article is a vial having a lubricated opening to receive a septum. Another aspect of the invention is a method of making such an article. |
| Inventor(s): | Jones; Joseph A. (Birmingham, AL), Weikart; Christopher (Auburn, AL), Martin; Steven J. (Midland, MI) |
| Assignee: | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) |
| Application Number: | 14/194,221 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,662,450
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech Inc | HERCEPTIN HYLECTA | trastuzumab; hyaluronidase-oysk | INJECTABLE;SUBCUTANEOUS | 761106 | 001 | 2019-02-28 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2029-05-13 | RX | search | |
| Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 002 | 2017-06-22 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2029-05-13 | RX | Orphan | search |
| Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 001 | 2017-06-22 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2029-05-13 | RX | Orphan | search |
| Wyeth Pharms Inc | MYLOTARG | gemtuzumab ozogamicin | VIAL;SINGLE-DOSE | 761060 | 001 | 2018-04-09 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2029-05-13 | RX | Orphan | search |
| Genentech Inc | OCREVUS | ocrelizumab | INJECTABLE;INJECTION | 761053 | 001 | 2017-03-28 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2029-05-13 | RX | search | |
| Janssen Biotech | STELARA | ustekinumab | INJECTABLE;INJECTION | 761044 | 001 | 2019-11-07 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2029-05-13 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
